12 weekS Adjuvant dOcetaxel Plus trastuzumaB in Patients With Small, Node-negative, HER2-positive Breast cancER (SOBER)
Clinical trial NCT03367676 · UNKNOWN
Trial details
- NCT number
- NCT03367676
- Sponsor
- Ruijin Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-30
- Primary completion
- 2021-01-01
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.